Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-01-06 Sale |
2021-01-07 6:11 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel |
25,000 | $72.41 | $1,810,346 | 293,375 (Direct) |
View |
2021-01-06 Sale |
2021-01-07 6:08 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
30,625 | $72.44 | $2,218,477 | 457,043 (Direct) |
View |
2021-01-05 Sale |
2021-01-07 6:02 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Senior Vice President |
38,750 | $72.51 | $2,809,578 | 136,250 (Direct) |
View |
2021-01-04 Sale |
2021-01-05 6:14 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
4,000 | $76.09 | $304,360 | 90,000 (Direct) |
View |
2021-01-04 Sale |
2021-01-05 6:11 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
4,000 | $76.08 | $304,320 | 119,368 (Direct) |
View |
2021-01-04 Sale |
2021-01-05 6:01 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director |
3,750 | $76.08 | $285,300 | 30,250 (Direct) |
View |
2020-12-17 Sale |
2020-12-18 6:26 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
9,575 | $79.32 | $759,443 | 129,738 (Indirect Direct) |
View |
2020-12-10 Sale |
2020-12-11 6:16 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director |
3,000 | $71.26 | $213,780 | 25,000 (Direct) |
View |
2020-12-08 Sale |
2020-12-10 7:07 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
55,000 | $68.73 | $3,780,347 | 4,224,999 (Direct) |
View |
2020-11-19 Sale |
2020-11-23 5:58 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Bradshaw Curt Chief Scientific Officer |
31,250 | $69.06 | $2,158,125 | 0 (Direct) |
View |
2020-11-19 Sale |
2020-11-20 6:03 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | San Martin Javier Chief Medical Officer |
19,500 | $69.39 | $1,353,105 | 130,500 (Direct) |
View |
2020-11-09 Sale |
2020-11-12 5:49 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
43,505 | $69.37 | $3,018,071 | 427,668 (Direct) |
View |
2020-10-08 Purchase |
2020-10-26 6:02 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director |
1,000 | $50.47 | $50,465 | 17,500 (Direct) |
View |
2020-10-23 Sale |
2020-10-23 7:35 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
100,000 | $58.21 | $5,821,032 | 2,505,237 (Direct) |
View |
2020-10-20 Sale |
2020-10-22 6:02 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
29,166 | $54.04 | $1,576,131 | 471,173 (Direct) |
View |
2020-10-09 Sale |
2020-10-13 6:01 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director |
10,000 | $48 | $480,000 | 30,971 (Direct) |
View |
2020-08-13 Sale |
2020-08-14 6:08 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
50,000 | $41.35 | $2,067,500 | 3,500,780 (Direct) |
View |
2020-06-25 Sale |
2020-06-26 6:02 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
100,000 | $38.81 | $3,881,017 | 2,605,237 (Direct) |
View |
2020-05-12 Sale |
2020-05-13 6:48 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
36,000 | $35.83 | $1,289,891 | 8,000 (Direct) |
View |
2020-05-11 Sale |
2020-05-13 6:45 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director |
26,000 | $36.54 | $950,040 | 28,000 (Direct) |
View |
2020-04-27 Sale |
2020-04-29 7:19 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer |
5,401 | $40 | $216,040 | 2,838,205 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-01-01 Option Award |
2021-01-05 6:27 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel |
60,000 | $0 | 318,375 (Direct) |
View |
2021-01-01 Option Award |
2021-01-05 6:24 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director |
9,000 | $0 | 39,971 (Direct) |
View |
2021-01-01 Option Award |
2021-01-05 6:22 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director |
9,000 | $0 | 26,500 (Direct) |
View |
2021-01-01 Option Award |
2021-01-05 6:20 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
60,000 | $0 | 487,668 (Direct) |
View |
2021-01-01 Option Award |
2021-01-05 6:16 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director |
9,000 | $0 | 14,000 (Direct) |
View |
2021-01-01 Option Award |
2021-01-05 6:14 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
9,000 | $0 | 90,000 (Direct) |
View |
2021-01-01 Option Award |
2021-01-05 6:11 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
9,500 | $0 | 119,368 (Direct) |
View |
2021-01-01 Option Award |
2021-01-05 6:07 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Senior Vice President |
50,000 | $0 | 175,000 (Direct) |
View |
2021-01-01 Option Award |
2021-01-05 6:01 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director |
9,000 | $0 | 30,250 (Direct) |
View |
2020-12-30 Gift |
2021-01-04 6:02 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
599 | $0 | 3,344,022 (Direct) |
View |
2021-01-01 Option Award |
2021-01-04 6:02 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
800,000 | $0 | 3,344,022 (Direct) |
View |
2020-12-28 Gift |
2020-12-30 5:52 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
1,126 | $0 | 2,544,621 (Direct) |
View |
2020-12-17 Gift |
2020-12-29 5:55 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
570 | $0 | 113,868 (Direct) |
View |
2020-12-18 Exercise |
2020-12-22 5:55 pm |
2013-10-01 2023-09-21 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
40,510 | $0 | 4,174,087 (Direct) |
View |
2020-12-18 Exercise |
2020-12-22 5:55 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
28,274 | $6.15 | 4,174,087 (Direct) |
View |
2020-12-18 Exercise |
2020-12-22 5:55 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
12,236 | $4.75 | 4,174,087 (Direct) |
View |
2020-12-07 Gift |
2020-12-18 6:26 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
46,500 | $0 | 129,738 (Direct) |
View |
2020-12-08 Exercise |
2020-12-10 7:07 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
55,000 | $2.01 | 4,224,999 (Direct) |
View |
2020-12-08 Exercise |
2020-12-10 7:07 pm |
2013-06-01 2023-05-06 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
55,000 | $0 | 4,224,999 (Direct) |
View |
2020-11-09 Exercise |
2020-11-12 5:49 pm |
2014-03-01 2024-02-06 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
43,505 | $0 | 427,668 (Direct) |
View |
2020-11-09 Exercise |
2020-11-12 5:49 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
43,505 | $14.54 | 427,668 (Direct) |
View |
Ownership |
2020-11-02 6:11 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Senior Vice President |
0 | $0 | 125,000 (Direct) |
View |
2020-10-20 Exercise |
2020-10-22 6:02 pm |
2016-02-01 2026-01-01 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
29,166 | $0 | 471,173 (Direct) |
View |
2020-10-20 Exercise |
2020-10-22 6:02 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
29,166 | $6.15 | 471,173 (Direct) |
View |
Ownership |
2020-09-08 6:31 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director |
0 | $0 | 5,000 (Direct) |
View |
2020-08-13 Exercise |
2020-08-14 6:08 pm |
2010-09-01 2020-08-16 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
50,000 | $0 | 3,500,780 (Direct) |
View |
2020-08-13 Exercise |
2020-08-14 6:08 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
50,000 | $9.9 | 3,500,780 (Direct) |
View |
2020-05-14 Exercise |
2020-05-18 6:27 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
5,000 | $2.01 | 335,000 (Direct) |
View |
2020-05-14 Exercise |
2020-05-18 6:27 pm |
2014-09-21 2023-09-21 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
77,000 | $0 | 335,000 (Direct) |
View |
2020-05-14 Exercise |
2020-05-18 6:27 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
15,000 | $2.19 | 335,000 (Direct) |
View |
2020-05-14 Exercise |
2020-05-18 6:27 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
25,000 | $4.2 | 335,000 (Direct) |
View |
2020-05-14 Exercise |
2020-05-18 6:27 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
10,000 | $2.62 | 335,000 (Direct) |
View |
2020-05-14 Exercise |
2020-05-18 6:27 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
15,000 | $5.19 | 335,000 (Direct) |
View |
2020-05-14 Exercise |
2020-05-18 6:27 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
7,000 | $4.75 | 335,000 (Direct) |
View |
2020-04-27 Exercise |
2020-04-29 7:19 pm |
2012-03-01 2020-02-16 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer |
4,397 | $0 | 2,838,205 (Direct) |
View |
2020-04-27 Exercise |
2020-04-29 7:19 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer |
1,030 | $5.19 | 2,838,205 (Direct) |
View |
2020-04-28 Exercise |
2020-04-29 7:19 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer |
500 | $7.75 | 2,838,205 (Direct) |
View |
2020-04-28 Exercise |
2020-04-29 7:19 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer |
1,454 | $14.54 | 2,838,205 (Direct) |
View |
2020-04-28 Exercise |
2020-04-29 7:19 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer |
1,200 | $4.75 | 2,838,205 (Direct) |
View |
2020-04-28 Exercise |
2020-04-29 7:19 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer |
213 | $5.2 | 2,838,205 (Direct) |
View |